Gene Therapy Restores Hearing in 90% of Deaf Patients
A groundbreaking gene therapy trial has restored hearing in 90% of people born profoundly deaf, with improvements lasting over two years. The treatment worked across ages from infants to adults, offering new hope beyond cochlear implants.